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1 Abstract 
Flaviviruses enter cells by receptor-mediated endocytosis and fuse their 
membrane with that of the endosome. Fusion is triggered by the acidic pH of this 
compartment and mediated by dramatic structural changes of the viral envelope 
protein E. Exposure to low pH induces an oligomeric rearrangement of E in which the 
subunits of the native E homodimers dissociate and the monomeric subunits then 
reassociate into more stable homotrimers. Crystal structures of truncated E proteins 
in their pre- and postfusion conformation lack the so called ‘stem’ region (located 
between the ectodomain and the membrane anchor) which is hypothesized to be 
critically required for fusion. Fusion models predict that during the dimer-trimer-
transition the stem „zippers“ along the trimer and that these interactions are essential 
for bringing the host and viral membrane into close proximity. This diploma thesis 
focused on the generation and characterization of soluble forms of E (sE) in their 
postfusion conformation with the stem (or parts thereof) for further analyses including 
the determination of the three-dimensional structures by X-ray crystallography. 
Knowledge of such structures would shed novel light on the precise role of the stem 
for membrane fusion. For this purpose, two different sE proteins of tick-borne 
encephalitis (TBE) virus were expressed using stably transfected Drosophila cell 
lines TBE sEH1H2, containing the whole stem region, and TBE sEH1, containing 
only parts of the stem. sEH1 was expressed with a strep tag which was also used for 
its purification. This protein was secreted predominantly as a dimer and after 
purification and removal of the tag the protein was converted into trimers by exposure 
to low pH in the presence of liposomes. The sEH1H2 protein, in contrast, was 
already found to be in its trimeric postfusion form in the cell culture supernatant. Due 
to the increased hydrophobicity of sEH1H2 compared to sEH1, detergents were 
required for purification experiments. Although further optimization will be necessary 
to obtain large amounts of highly purified sEH1H2 trimers for crystallization, 
preliminary studies with monoclonal antibodies were possible and allowed the 
identification of important interactions of the stem-region with other parts of E in the 
postfusion trimer. 
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Zusammenfassung 
Flaviviren dringen mittels Rezeptor-vermittelter Endozytose in Zellen ein und 
fusionieren ihre Membran mit der des Endosoms. Fusion wird durch dramatische 
strukturelle Änderungen des virale Hüllproteins E (“envelope“) vermittelt, die der 
saure pH des Endosoms induziert. Eine Reorganisation der Oligomere des 
E-Proteins ist die Folge, bei der die Untereinheiten des E-Proteins in Monomere 
dissoziieren und sich aus diesen stabilere Trimere formen. Den bisher bekannten 
Kristallstrukturen der E-Proteine vor und nach der Fusion (Prä- und 
Post-Fusions-Struktur) fehlt die so genannte "Stamm" Region (zwischen der 
Ektodomäne und dem Membran-Anker) und die Transmembranregion. Der Stamm 
ist vermutlich für die Fusion essentiell. In Fusionsmodellen wird vorgeschlagen, dass 
während der Dimer-Trimer-Umlagerung der Stamm sich reißverschlussartig am 
Trimer anlagert (“zippering“) und dass diese Wechselwirkungen für die räumliche 
Annäherung von der viralen Membran an die Membran der Wirtszelle wesentlich 
sind. 
Diese Diplomarbeit konzentrierte sich auf die Herstellung und Charakterisierung 
von löslichen Formen des E-Proteins (sE) in seiner Post-Fusions-Konformation, die 
den Stamm oder Teilen davon enthält. Diese Proteine können für weitere Analysen 
verwendet werden, vor allem für die Bestimmung der dreidimensionalen Strukturen 
mit Hilfe der Röntgenkristallographie. Die Kenntnis solcher Strukturen kann zu einem 
besseren Verständnis für die Rolle des Stamms in der Membranfusion führen. Zu 
diesem Zweck wurden zwei unterschiedliche sE Proteine des Frühsommer-
Meningoenzephalitis (FSME)-Virus in stabil transfizierten Drosophila-Zelllinien 
exprimiert: TBE sEH1H2, das die gesamte Stamm-Region enthält und TBE sEH1, 
das nur Teile des Stamms enthält. sEH1 wurde mit einem Strep-Tag hergestellt, der 
auch für die Reinigung des Proteins verwendet wurde. sEH1 wurde überwiegend als 
Dimeres sezerniert und, nach der Aufreinigung und der Entfernung des Tags, in 
Gegenwart von Liposomen bei saurem pH trimerisiert. Im Gegensatz dazu lag 
sEH1H2 bereits als Trimeres im Zellkulturüberstand vor. Aufgrund der erhöhten 
Hydrophobizität von sEH1H2 im Vergleich zu sEH1 waren Detergenzien für die 
Aufreinigung erforderlich. Obwohl weitere Optimierungen notwendig sind, um große 
Mengen an hochreinen sEH1H2 Trimeren zur Kristallisierung herzustellen, erlaubten 
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vorläufige Untersuchungen mit monoklonalen Antikörpern die Identifizierung von 
wichtigen Wechselwirkungen der Stamm-Region mit anderen Teilen des E-Proteins 
im Post-Fusions-Trimer. 
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2 Introduction 
2.1 General introduction 
2.1.1 Family Flaviviridae, genus Flavivirus 
The family Flaviviridae comprises three genera: Flavivirus (Latin “flavus” 
meaning yellow) Pestivirus (Latin “pestis” meaning plague) and Hepacivirus (“hepar” 
translated from Greek as liver). All three genera show similarities in replication, 
morphology and composition of the viral genome (Lindenbach B.D. Thiel H-J., 2007).  
Flavivirus is the largest of the three genera and contains more than 70 distinct 
viruses. This genus can be subdivided into serocomplexes and phylogenetical 
groups (Kuno et al., 1998) (Figure 1). 
 
Figure 1 Flavivirus classification. Relationships are depicted according to the identity of the 
amino acid sequence of the envelope protein (E protein). Four serocomplexes are shown: in 
red: DENV (dengue virus) serocomplex, green: JEV (japanese encephalitis virus) 
serocomplex, yellow: YFV (yellow fever virus) serocomplex and in blue: TBEV (tick-borne 
encephalitis virus) serocomplex. On the right side the corresponding transmission vector is 
shown. (Figure adapted from (Stiasny et al., 2006) 
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The majority of flaviviruses is arthropod-borne either by ticks or mosquitoes, but 
for some flaviviruses the vector is unknown (Kuno et al., 1998). Tick-borne 
encephalitis virus (TBEV) is transmitted by ticks, while other important human 
pathogens, like yellow fever virus (YFV), dengue viruses (DENV 1-4), Japanese 
encephalitis virus (JEV) and West Nile virus (WNV) are transmitted by mosquitoes 
(Gubler, 2007) (Figure 1). 
 
 
2.1.2 Transmission, epidemiology 
TBEV is transmitted by infected ticks that pass the virus on in their saliva. In 
addition, milk-borne TBE is possible after consumption of unpasteurized milk or milk-
products from viraemic animals, especially goats (Holzmann et al., 2009; Lindquist 
and Vapalahti, 2008). 
TBEV is endemic in many European countries, Asian parts of Russia, northern 
Japan and northern China. The habitat of ticks is restricted by suitable temperatures 
(6-25 C°) and a humidity higher than 85% (Lindquist and Vapalahti, 2008). Three 
subtypes of TBEV are described: the European, the Sibirian and the Far Eastern 
subtype (Ecker et al., 1999). The European subtype is transmitted by Ixodes ricinus, 
while the other two subtypes use Ixodes persulcatus as a vector (Lindquist and 
Vapalahti, 2008). Within a subtype a low variation in the amino acid sequence of the 
E protein of maximal 2.2% was found; between the three different subtypes the 
maximum of variation was 5.6% (Ecker et al., 1999). 
 
 
2.2 Morphology and Organization 
2.2.1 Genome 
The genome of flaviviruses is organized in a positive single stranded RNA of 
approximately 11 kb (Figure 2). A single open reading frame (ORF) encodes seven 
non-structural (NS1, NS2a, NS2b, NS3, NS4a, NS4b, NS5) and three structural 
proteins (capsid C, envelope E and precursor of membrane protein prM/M). The ORF 
is flanked by 3’ and 5’ non coding (NCR) regions that are important for replication. 
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The 5’ end is capped by m7GpppAmpN2 (Lindenbach B.D. Thiel H-J., 2007). The 
ORF is translated into one large polyprotein, that is proteolytically processed into the 
viral proteins (Lindenbach B.D. Thiel H-J., 2007) (Figure 3). 
 
Figure 2 Schematic representation of the flavivirus RNA genome (not to scale). The open 
reading frame (ORF) codes for structural and non-structural proteins. Non coding regions at 
the 3’ and 5’ ends flank the ORF. 
 
 
Figure 3 Schematic representation of the endoplasmic membrane topology of the flavivirus 
polyprotein. In red protein C, in blue glycoprotein prM, in green envelope glycoprotein E and 
in grey the non-structural proteins. (Figure adapted from (Umareddy et al., 2007)) 
 
 
2.2.2 Structural organization of flaviviruses 
Flaviviruses are enveloped viruses with an icosahedral organized envelope of 
approximately 500 Å in diameter (Mukhopadhyay et al., 2005). Three proteins build 
the viral particle: two membrane associated proteins (prM/M, E) and the capsid 
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protein (C) that builds together with the viral genome the nucleocapsid. Virions are 
assembled as immature particles, containing prM/E heterodimers that form trimeric 
spikes (Zhang et al., 2003b). During maturation the pr-peptide is proteolytically 
cleaved leaving the M protein anchored in the lipid bilayer and conformational 
changes take place on the viral surface (Lindenbach B.D. Thiel H-J., 2007; 
Mukhopadhyay et al., 2005). 
The mature virion has a smooth, tightly packed surface with the E protein in a 
dimeric conformation (Kuhn et al., 2002; Mukhopadhyay et al., 2003; Mukhopadhyay 
et al., 2005) (Figure 4). 
 
Figure 4 Flavivirus particles. Left: immature particles with heterodimeric prM/E complexes. 
Right: mature particles with E homodimers. (Figure adapted from (Stiasny and Heinz, 2006)) 
 
 
2.2.3 Life cycle 
The viral life cycle (Figure 5) starts with the attachment of the virion to the cell 
by receptor binding of the E protein. This is followed by receptor-mediated clathrin-
dependent endocytosis (van der Schaar et al., 2008). Due to the acidic pH (< 6.6) in 
the endosome, structural alterations are induced in E, leading to fusion of the viral 
membrane with the endosomal membrane. Subsequently, the viral nucleocapsid is 
released into the cytoplasm. After uncoating the positive stranded RNA genome is 
replicated and translated. Virus assembly occurs in the endoplasmic reticulum (ER), 
leading to the formation of non-infectious immature virions. In this state, prM is 
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associated with E in a heterodimeric complex to prevent E-mediated fusion (Heinz et 
al., 1994). During exocytosis prM is cleaved by furin or a furin-like protease in the 
trans-Golgi network (TGN) before virions are released from the cell (Mukhopadhyay 
et al., 2005). The neutral pH in the extracellular space causes the pr-part to detach 
from the viral particle (Yu et al., 2008) resulting in mature infectious particles. 
Together with infectious virus particles slowly-sedimenting hemagglutinin (SHA) 
particles are released from infected cells (Heinz and Kunz, 1977). SHA particles lack 
the nucleocapsid and are therefore noninfectious (Lindenbach B.D. Thiel H-J., 2007).  
 
 
Figure 5 Schematic representation of the flavivirus life cycle. 
ER: endoplasmic reticulum 
TGN: trans-Golgi Network 
SHA: Slowly-sedimenting hemagglutinin 
(Figure adapted from (Stiasny and Heinz, 2006)) 
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2.2.4 Structural proteins 
2.2.4.1 C protein 
The C protein (11 kd) is highly basic and largely α-helical with internal 
hydrophobic regions (Mukhopadhyay et al., 2005). Due to the positive charge of the 
protein, it associates with the negatively charged viral genome (Lindenbach B.D. 
Thiel H-J., 2007; Mukhopadhyay et al., 2005). The hydrophobic regions interact with 
the viral membrane (Lindenbach B.D. Thiel H-J., 2007; Mukhopadhyay et al., 2005). 
 
 
2.2.4.2 Membrane glycoprotein prM / M 
The main function of prM is to assist the E protein in proper folding and to 
prevent the conversion of E into its fusogenic state in acidic compartments of the 
secretory pathway (Lindenbach B.D. Thiel H-J., 2007; Lorenz et al., 2002). 
The membrane protein is expressed as prM, the precursor of the M protein. The 
prM protein is about 26 kd and its N-terminal region contains three N-linked 
glycosylation sites and six conserved cystein residues that build three disulphide 
bridges (Chambers et al., 1990; Nowak et al., 1989).  
The prM protein is integrated into the ER membrane by two trans-membrane 
spanning helices (Figure 3). In immature viruses, it forms heterodimers with the E 
protein. During exocytosis of these particles, prM is cleaved by furin. Upon secretion 
into the neutral pH of the extracellular space the pr-part of prM dissociates (Li et al., 
2008; Stiasny et al., 1996; Yu et al., 2009), M (about 8kd) remains associated with 
the viral particles and E forms homodimers (Lindenbach B.D. Thiel H-J., 2007; 
Mukhopadhyay et al., 2005).  
 
 
2.2.4.3 Envelope glycoprotein E  
The E protein mediates important functions during cell entry, i.e. receptor 
binding and membrane fusion after virus uptake by endocytosis (Kaufmann and 
Rossmann, 2011; Kielian, 2006; Lindenbach B.D. Thiel H-J., 2007; Stiasny and 
Heinz, 2006). 
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After the E protein is cleaved by a host signalase it is anchored in the 
membrane by two transmembrane domains (Figure 3). Twelve cysteines form 
disulphide bonds and E can be glycosylated and in most flavivirus species E contains 
an N-type linked oligosaccharide (Lindenbach B.D. Thiel H-J., 2007). 
The size of the E protein is approximately 53kd. The crystal structure of the 
soluble ectodomain of the E protein (sE; residues 1-400) has been solved for several 
flaviviruses (Luca et al., 2011; Modis et al., 2003; Modis et al., 2005; Nybakken et al., 
2006; Rey et al., 1995; Zhang et al., 2004). The crystallized ectodomain is connected 
to the double membrane anchor via the “stem” region that contains two amphipathic 
helices, helix 1 and helix 2 (Zhang et al., 2003a). The ectodomain possesses three 
distinct structurally defined domains: The central domain I (DI) at the N-terminus, the 
dimerization region domain II (DII) and the Ig-like domain III (DIII) at the C-terminus. 
In all three domains, ß-sheets are predominant and all domains are joined by flexible 
hinges (Rey et al., 1995) (Figure 6). The tip of domain II contains a hydrophobic, 
conserved sequence element (fusion peptide), that is important for membrane fusion 
(Allison et al., 2001). 
 
Figure 6 Ribbon diagrams of the sE dimer (A) top view and (B) side view. Color code: DI in 
red, DII in yellow, DIII in blue, fusion peptide (fp) in orange. (Figure adapted from (Stiasny 
and Heinz, 2006)) 
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2.2.4.4 The stem anchor region of E 
The region connecting the E protein ectodomain to the double trans-membrane 
anchor, the so called “stem” is about 50 amino acids long (Stiasny et al., 1996; Zhang 
et al., 2003a). It includes two amphipathic helices, helix 1 and helix 2, flanking a 
central conserved sequence (CS) element (Zhang et al., 2003a) (Figure 7). The stem 
region has increasing hydrophobicity towards the C-terminus (Schmidt et al., 2010b). 
Cryo-EM has shown that the stem helices are half buried in the outer leaflet of 
the viral membrane, underneath the ectodomain (Zhang et al., 2003a).  
 
 
Figure 7 Carboxy terminal amino acid sequence of TBEV. Highlighted in black are amino 
acids conserved among flaviviruses. Red dots indicate hydrophobic amino acids. The two 
stem helices are depicted underneath the sequence according to helix prediction from 
Stiasny et al. (figure adapted from (Stiasny et al., 1996)). 
 
 
2.2.4.5 Structural organization of flavivirus particles 
Cryo-EM studies and image reconstruction of mature flaviviruses particles 
revealed an icosahedral organization of the virus surface. 180 E proteins form a 
herringbone-like lattice of 30 rafts of 3 E protein homodimers (Kuhn et al., 2002; 
Mukhopadhyay et al., 2003) (highlighted in figure 8B). Mature viruses have a smooth, 
spikeless envelope of 50nm diameter.  
Immature virions are slightly bigger, with a diameter of about 60 nm 
(Lindenbach B.D. Thiel H-J., 2007) and contain 60 spikes on their surface, each 
composed of three prM/E heterodimers (Zhang et al., 2003b) (Figure 8A). 
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Figure 8 Pseudo-atomic structures of the surface of immature (A) and mature (B) flavivirus 
virions based on cryo-EM reconstructions.(B) A raft of three dimers is highlighted. Color 
code: DI in red, DII in yellow and DIII in blue, fusion peptides in green. (Figure from 
(Mukhopadhyay et al., 2005))  
 
 
2.3 Membrane Fusion 
2.3.1 Viral fusion proteins  
In the life cycle of an enveloped virus, membrane fusion with its target cell is a 
crucial event. This process has to be tightly regulated to occur at the right time and 
place (Harrison, 2008). Membrane fusion is mediated by viral fusion proteins 
(glycoproteins) that are present in a metastable conformation on the surface of 
mature virions and undergo triggered conformational changes necessary for fusion 
(Harrison, 2005; Schibli and Weissenhorn, 2004). Possible triggers are (i) receptor 
binding, (ii) exposure to a low pH or (iii) both (White et al., 2008). 
Three structural classes of viral fusion proteins can be distinguished 
(Weissenhorn et al., 2007; White et al., 2008): 
Class I: Members of class I, such as orthomyxo-, paramyxo-, retro-, corona- and 
filoviruses share similarities with cellular SNARE fusion proteins (Skehel and Wiley, 
1998). The structure of class I is characterized by homotrimers with a central α-
helical coiled-coil (Kielian and Rey, 2006). The fusion peptide of class I is located at 
or near the N-terminus of the fusion subunit (White et al., 2008). For class I fusion 
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proteins processing of the fusion protein itself is typically required to be fusion 
competent (Harrison, 2005; Skehel and Wiley, 2000). 
Class II proteins of flavi- (E) and alphaviruses (E1) possess internal fusion 
peptide loops between two ß-sheets. E and E1 are oriented parallel to the viral 
membrane and build an icosahedral oligomeric network (Harrison, 2008; Kuhn et al., 
2002; White et al., 2008; Zhang et al., 2003a). 
Class III fusion proteins are found in rhabdo-, herpes- and baculoviruses 
(Backovic and Jardetzky, 2009). They share similarities with both, class I and class II 
fusion proteins (Weissenhorn et al., 2007). Class III fusion proteins possess an 
internal fusion loop that is not as conserved as in class I and class II fusion proteins 
(Backovic and Jardetzky, 2009). The fusion loop of class III fusion proteins is located 
in domain I.  
 
Despite the structural unrelatedness, all fusion proteins undergo conformational 
changes that mediate fusion involving the exposure of the fusion peptide that 
interacts with the target membrane and the formation of a hairpin-like postfusion 
structure with the fusion peptide and the transmembrane anchors juxtaposed at the 
same end of the protein rod (Kielian and Rey, 2006; Stiasny and Heinz, 2006; 
Weissenhorn et al., 2007). 
 
 
2.3.2 Class II viral fusion protein E 
The structure of the ectodomain of the truncated envelope glycoprotein E has 
been resolved in its pre- and the postfusion conformation for several flaviviruses 
(Bressanelli et al., 2004; Kanai et al., 2006; Luca et al., 2011; Modis et al., 2003; 
Modis et al., 2004; Modis et al., 2005; Nayak et al., 2009; Nybakken et al., 2006; Rey 
et al., 1995; Zhang et al., 2004). 
As outlined in “2.2.4.3 Envelope glycoprotein E” the ectodomain possesses 
three domains (DI, DII and DIII).  
In the metastable, mature prefusion conformation, the dimer has a head-to-tail 
arrangement and is orientated parallel to the viral membrane (Rey et al., 1995). The 
fusion peptide at the tip of DII is buried in a hydrophobic pocket provided by DI and 
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DIII of the partner subunit. An oligosaccharide additionally covers the fusion peptide 
(Rey et al., 1995) (Figure 9 A, B).  
In the postfusion conformation, the E protein forms trimers that are orientated 
perpendicular to the membrane and the domains are arranged head-to-head 
(Bressanelli et al., 2004; Modis et al., 2004; Nayak et al., 2009) (Figure 9 C, D). DII is 
rotated 19° around the DI/ DII hinge and DIII is relocated to the side of DI, 33 Å from 
its prefusion position (Bressanelli et al., 2004; Modis et al., 2004) (Figure 10). This 
enables the formation of a hairpin-like structure in which the fusion peptide is 
juxtaposed to the membrane anchors (Bressanelli et al., 2004). Although the domains 
change their position towards each other, their original folds remain (Stiasny and 
Heinz 2006). 
 
 
Figure 9 Ribbon diagrams and schematics of the TBEV E protein in its pre- and postfusion 
state. (A, B) The dimeric prefusion conformation. (C, D) The trimeric postfusion conformation. 
The position of the stem anchor region is based on the study of (Bressanelli et al., 2004). 
Color code: DI in red, DII in yellow and DIII in blue, fusion peptides in orange, stem region in 
purple, transmembrane region in green. (Figure adapted from (Stiasny and Heinz, 2006))  
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Figure 10 Ribbon diagrams of monomeric subunits before (A) and after (B) fusion. Color 
code: DI in red, DII in yellow and DIII in dark blue, fusion peptides in orange. Arrows indicate 
the direction of rotation. C-terminus is depicted as asterisk. (Figure from (Bressanelli et al., 
2004)). 
 
 
2.3.2.1 Flavivirus fusion mechanism  
Fusion of flaviviruses is a fast and efficient process (Stiasny and Heinz, 2006). 
A fusion model was developed based on the X-ray structures of the pre- and 
postfusion E proteins together with biochemical studies (Figure 11 A-E). Flaviviruses 
enter the host cell by receptor-mediated endocytosis. In the endosomal compartment, 
the virus is exposed to acidic pH that triggers the E protein dimers to dissociate 
(Stiasny et al., 1996). In this monomeric state the fusion peptides are exposed and 
are able to insert into the target membrane (Stiasny et al., 2002). It has been 
speculated that the extension of the stem facilitates the insertion of the fusion peptide 
into the target membrane (Kaufmann et al., 2009) (Figure 11 B). 
At this stage the two lipid bilayers are held together by the E protein; on one 
side anchored in the viral membrane by the transmembrane domain, on the other 
side attached to the target membrane via the fusion peptides. As the conformational 
change proceeds - involving the relocation of DIII and trimerization - the two 
membranes are drawn together (Figure 11 C-E). The protonation of amino acid 
residues at the domain I / domain III interface has been shown to be essential for the 
destabilization of this region (Fritz et al., 2008), which is necessary for the release of 
the fusion peptide from its buried position in the dimer as well as for the relocation of 
DIII. Fusion is then believed to continue by “zippering” of the stem along the body of 
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the trimer (Figure 11 C, D), thus forcing the formation of a hemifusion intermediate 
with only the outer leaflets fused (Figure 11 D) (Schmidt et al., 2010b). The final step 
would be the juxtaposition of the membrane anchor and the fusion peptides 
(postfusion structure) for the formation of a fusion pore (Figure 11 E). 
 
Figure 11 Proposed fusion process for class II. The color code referring to the domains: DI in 
red, DII in yellow, DIII in blue, fusion peptide in orange, stem region in blue, transmembrane 
region in green. Mechanism as explained in the text (Figure from (Stiasny and Heinz, 2006))  
 
 
2.3.2.2 The stem and flavivirus membrane fusion 
The structure of sE in its postfusion conformation has been elucidated 
(Bressanelli et al., 2004; Modis et al., 2004; Nayak et al., 2009), but the arrangement 
of the stem region is not known. In a modeling analysis, stem helix 1 could be fitted 
into the groove of two adjoining DII of the sE postfusion structure (Bressanelli et al., 
2004), but not helix 2 (Figure 12). It is therefore possible that the postfusion 
conformation of the E protein, including the stem, could be different from the stem-
less truncated version (Bressanelli et al., 2004). 
In the fusion process, the stem is thought to play an important role, providing 
part of the energy for fusion by zippering. Schmidt et al., 2010 have shown that 
externally applied DENV E protein stem peptides inhibited viral infectivity (Schmidt et 
al., 2010a) and that such peptides could cross-inhibit different dengue viruses, but 
not other flaviviruses (Schmidt et al., 2010b). 
Additionally, a mutagenesis study has revealed that a specific interaction 
between a hydrophobic pocket in DII and helix 1 of the stem is necessary in late 
stages of the fusion process and contributes to the stability of the postfusion trimer 
(Pangerl et al., 2011). Consistent with this finding, it was shown that the 
thermostability of full-length trimers was higher than that of truncated sE 
 
 A                 B                  C                            D                                     E 
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trimers (Stiasny et al., 2005). 
Figure 12 Surface representation of part of the sE trimer with the stem helix 1 (pink) 
modeled into the grooves formed by domain IIs. The crystallized c-terminus is labelled with a 
white star. (Figure adapted from (Bressanelli et al., 2004)) 
 
 
2.3.2.3 Comparison of the E protein with the alphavirus fusion protein E1 
Despite the absence of sequence conservation, the structures of the alphaviral 
and flaviviral ectodomains of the fusion proteins are homologous in their secondary 
and tertiary structures (Lescar et al., 2001) (Figure 13). Both viruses share the overall 
organisation of the fusion protein into three domains (DI, DII, DIII), including the 
position of the fusion peptide at the tip of DII (Bressanelli et al., 2004; Lescar et al., 
2001). 
Regardless of several shared features of the class II fusion proteins of 
alphaviruses and flaviviruses, there are some differences in the fusion machinery: 
On the surface of flaviviruses the E protein is present in a herring-bone-like 
pattern of rafts of three homodimers (Kuhn et al., 2002; Mukhopadhyay et al., 2003; 
Mukhopadhyay et al., 2005; Zhang et al., 2004). In contrast, 80 trimeric spikes of E1/ 
E2 heterodimers cover the surface of mature alphaviruses in a T=4 symmetry 
(Mukhopadhyay et al., 2006; Strauss et al., 2002; von Bonsdorff and Harrison, 1975). 
The E protein of flaviviruses is responsible for both entry functions, binding to 
the cell receptor and fusion, whereas E1 mediates fusion and E2 is the receptor-
binding protein (Mukhopadhyay et al., 2006). 
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The ~54 amino acids long stem region of TBEV has a conserved secondary 
structure (Stiasny et al., 1996; Zhang et al., 2003a). In alphaviruses the stem is less 
ordered and has a length of ~30 amino acids (Liao and Kielian, 2006a; Liao and 
Kielian, 2006b). It was shown that a minimal stem length of at least 9 amino acids 
was required for fusion (Liao and Kielian, 2006a). 
The E protein of flaviviruses is anchored with a double transmembrane region in 
the viral membrane (Zhang et al., 2003a). In contrast, the alphavirus glycoprotein E1 
has a single transmembrane domain (Jose et al., 2009; Strauss et al., 2002).  
In the flavivirus postfusion trimer the fusion peptides interact with each other 
(“closed conformation”), whereas in the E1 postfusion trimer the three fusion peptides 
are about 45 Å apart (“open conformation”) (Bressanelli et al., 2004; Gibbons et al., 
2004a) (Figure 13 B, D). 
 
Figure 13 Ribbon diagrams and schematic representations of flavivirus (TBEV) and 
alphavirus (SFV) fusion proteins. Pre-fusion conformation (A, C) and postfusion conformation 
(B, D) of the E1 (SFV) and the E (TBEV) ectodomain. Color code: DI in red, DII in yellow, DIII 
in blue, fusion peptide (fp) in green. (Figure adapted from (Sanchez-San Martin et al., 2009)) 
A 
B 
C 
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2.4 Expression of Recombinant Flavivirus Proteins 
Various methods for the expression of recombinant proteins of flaviviruses have 
been described (Allison et al., 1995b; Altmann et al., 1999; Bressanelli et al., 2004; 
Demain and Vaishnav, 2009; Hacker et al., 2009; Heinz et al., 1995; Jaiswal et al., 
2004; Lieberman et al., 2007; Liu et al., 2010; Maroni et al., 1986; Modis et al., 2003; 
Modis et al., 2004; Modis et al., 2005; Sugrue et al., 1997a; Sugrue et al., 1997b; 
Tripathi et al., 2008; Volk et al., 2007; Volk et al., 2009; Zhang et al., 2004).  
The choice of the appropriate expression system depends on the yield and on 
the particular requirements of the protein to obtain it in its native structure. Specific 
characteristics such as posttranslational modifications (disulphide bridges and 
glycosylation) determine the proper folding of a protein and are crucial for its function. 
For glycosylation eukaryotic cells are obligate. Naturally, flaviviruses replicate in 
mammalian and insect cells. Therefore these cell lines are suitable for the correct 
expression of recombinant proteins.  
 
 
2.4.1 Expression of recombinant proteins in bacterial expression systems 
For the production of recombinant proteins, the most commonly used bacterium 
is Escherichia coli (E. coli) (Demain and Vaishnav, 2009). E. coli is an inexpensive 
system and its genetics are well understood. Its genome can be easily and precisely 
modified. Rapid expression and high yields of the desired protein are additional 
advantages (Demain and Vaishnav, 2009). Drawbacks are the possible expression of 
proteins in inclusion bodies and the missing posttranslational modifications. The 
bacterial expression system is therefore mainly used for bacterial proteins. However, 
for some mammalian proteins the posttranslational modification can be neglected like 
γ-interferon (Demain and Vaishnav, 2009). Bacterial expression of DIII in its native 
fold was shown for WNV (Volk et al., 2004; Zlatkovic et al., 2011) YFV (Volk et al., 
2009), DENV (Jaiswal et al., 2004; Tripathi et al., 2008; Volk et al., 2007; Volk et al., 
2009) and Omsk hemorrhagic fever virus (Volk et al., 2006). 
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2.4.2 Expression of recombinant proteins in yeast expression systems 
Yeast is a eukaryotic fungal organism that is often used for protein expression 
due to costefficient high production of recombinant proteins. A further advantage is 
the secretion of expressed proteins. Saccharomyces cervisiae and Pichia pastoris 
are the most commonly used strains and are genetically well characterized. Protein 
processing and posttranslational modifications are similar to mammalian cells. Yeast 
strains can assist protein folding and handle disulphide bridge rich proteins. In 
contrast to mammalian cells, yeast produces o-linked oligosaccharides containing 
only mannose and not sialylated o-linked chains (Demain and Vaishnav, 2009). The 
production of recombinant DENV E protein in Pichia pastoris was not successful due 
to proteolytic degradation (Sugrue et al., 1997a), but immunogenic DENV 1 virus-like 
particles (VLPs) could be produced, although Pichia pastoris was unable to modify 
one of the two available glycosylation sites (Sugrue et al., 1997b).The production of 
VLPs was also successful for DENV 2 (Liu et al., 2010) 
 
 
2.4.3 Expression of recombinant proteins in insect expression systems 
The moderate growth rate of insect cells is a shortcoming of the insect 
expression system. Still, it is a favourable expression system for the production of 
mammalian proteins due to high expression rates and fast and easy scale up. 
Posttranslational modifications are similar to mammalian cells (Demain and 
Vaishnav, 2009), although insect cells differ particularly in N-glycosylation from 
mammalian cells (Altmann et al., 1999; Hacker et al., 2009; Kim et al., 2005). Two 
systems were used for flavivirus protein production: the baculovirus expression 
system and the Drosophila expression system (DES). In the baculovirus expression 
system, Spodoptera frugiperda cells are used (Demain and Vaishnav, 2009). In DES, 
an inducible expression of stable cell lines is possible, for the use of a metallothionein 
promotor and heavy metals for induction (Maroni et al., 1986). 
The insect expression system is therefore well suited for the production of 
flavivirus proteins. Several proteins have been successfully produced, among them 
the WNV sE with a baculovirus shuttle vector in Hi-5 insect cells (Nybakken et al., 
2006), sE of WNV (Lieberman et al., 2007; Zlatkovic et al., 2011), sE of TBEV 
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(Zlatkovic et al., 2011) and sE of DENV 2 and DENV 3 (Modis et al., 2003; Modis et 
al., 2004; Modis et al., 2005) in the DES system. 
 
 
2.4.4 Expression of recombinant proteins in mammalian expression systems 
Expression in mammalian expression systems guarantees proper folding, 
addition of fatty acid chains, production of complex glycans and phosphorylations 
(Demain and Vaishnav, 2009; Hacker et al., 2009) that insect expression cells cannot 
accomplish. 
Poor secretion, long incubation periods and high costs are the downside. 
The expression of flaviviral proteins is well established in various mammalian 
cell lines. Recombinant subviral particles (RSPs) of JEV& DENV 1-4 (Konishi et al., 
1992; Mason et al., 1991; Wang et al., 2009) have been produced in HeLa cells with 
a recombinant vaccinia virus encoding prM and E genes. Furthermore, VLPs of WNV 
have been generated in CHO cells (Ohtaki et al., 2010) and DENV VLPs were 
expressed in COS-1 (Crill et al., 2009).The expression of TBEV E protein, sE protein 
and RSPs has been established in COS-1 cells (Allison et al., 1995b; Heinz et al., 
1995; Schalich et al., 1996) and VLPs of JEV in RK13 cells (Kojima et al., 2003). 
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3 Objectives 
The final postfusion structure of a soluble fragment of the fusion protein E (sE) 
is known, but important elements (including the two helices of the stem region and 
the transmembrane anchor) have not been resolved. According to the fusion model, 
the “zippering” of the stem along DII during the conformational changes of E might be 
important for the formation of a hemifusion intermediate and the stable hairpin-like 
postfusion trimer. Modeling studies allowed the positioning of the first helix (H1) into 
the truncated postfusion structure of sE, but it was not possible to place the second 
helix (H2), indicating that – in the presence of the stem – the postfusion structure 
could be different. It was therefore the aim of this thesis to generate and characterize 
different recombinant postfusion sE trimers of tick borne encephalitis virus: 1) sE with 
the first helix (sEH1) 2) sE with helix1 and a truncated stem helix 2 (lacking the last 
four carboxy-terminal residues of helix 2; sEH1H2 444) and 3) sE with both stem 
helices (sEH1H2 448). Using the Drosophila expression system (DES), Schneider S2 
cell lines that stably express TBE virus sEH1, sEH1H2 444 and sEH1H2 448 fused to a 
cleavable protein tag will be established. Purification and conversion into the trimeric 
postfusion forms will be carried out as described previously. The obtained postfusion 
trimers will be characterized and - after large scale expression and purification – can 
be further used for the determination of their X-ray crystal structures. This should 
lead to new insights into the role of the stem region during the membrane fusion 
process, thus contributing to the understanding of the flavivirus fusion mechanism. 
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4 Material and Methods 
4.1 Manipulation of nucleic acids 
4.1.1 Plasmids 
For the production of recombinant TBEV sE proteins in the Drosophila 
Expression System (DES), the expression plasmid pT389-sEH1H2 448 dstrep was used 
(Geller, 2009). This expression plasmid pT389-sEH1H2 448 dstrep consists of the pT389 
vector with an expression cassette, containing the sequence encoding the prM and 
the E protein (amino acids 1-448) of TBEV strain Neudoerfl (Mandl et al., 1988). The 
pT389 vector (provided by the Institut Pasteur, France) contains the Drosophila 
signal sequence Bip that is important for secretion of the target proteins, a pUC origin 
for replication in bacterial cells, a metallothionin (MT) promoter for inducible 
expression of target genes (Invitrogen TM, Life Technologies) (Bunch et al., 1988; 
Maroni et al., 1986), an ampicillin resistance for selection in bacterial cells, an 
enterokinase cleavage site and two strep tags for purification of the target protein. 
 
 
4.1.2 DNA digestion and restriction enzymes 
For digestion of vector pT389-sEH1H2 448 dstrep and the synthesized plasmid, 
sEH1H2_del, 2µg DNA were incubated with the enzymes ApaI and PasI (Fermentas) 
according to manufacturer’s protocols. The restriction was controlled by agarose gel 
electrophoresis (4.1.3). 
 
 
4.1.3 Agarose gel electrophoresis 
DNA fragments were separated on a 1% (w/v) agarose gel containing 2.5µg/ml 
ethidium bromide. Lambda phage digested with HindIII (fragment sizes in bp: 23130, 
9416, 6557, 4361, 2322, 2027, 564 and 125) was used as a size marker. DNA 
fragments were separated for 30-50 minutes at 120V and visualized, using a trans-
illuminator at a wavelength of 320nm. 
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4.1.4 Preparative agarose gel and DNA extraction 
For purification of DNA fragments after digestion, an agarose gel 
electrophoresis was performed as described in 4.1.3, using the whole digestion mix. 
The desired bands were excised from the gel under UV light and DNA was extracted 
with Wizard® SV Gel and PCR Clean-Up System purchased from Promega. 
 
 
4.1.5 Ligation 
Ligation of DNA fragments was performed with T4 DNA Ligase (Fermentas) at a 
ratio of 5:1 of insert and vector. The reaction mix was incubated at room temperature 
for ten minutes and directly used for the transformation of chemically competent 
Escherichia coli cells (4.1.7).  
 
 
4.1.6 Site Directed Mutagenesis 
In order to generate sEH1H2 constructs without a strep tag (sEH1H2) or with a 
single strep tag (sEH1H2 strep), site directed mutagenesis (GeneTailor™ Site-Directed 
Mutagenesis System from Invitrogen™) was performed according to the 
manufacturer’s protocol. The sequences of the primers (VBC Biotech Services 
GmbH) used for the mutagenesis PCR and the PCR conditions are listed in table 1 
and 2. All expression plasmids were amplified in Escherichia coli strain DH5α-T1R 
(4.1.7-4.1.8) and the sequences were controlled (4.1.10) before expression in 
Drosophila Schneider 2 cells (4.2). 
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Table 1 Conditions for PCR reaction 
sEH1H2 STOP    sEH1H2 STREP    
Initial denaturation  
Denaturation 
Annealing 
Extension 
Final Extension 
End 
98 °C   2’ 
98 °C   30’’ 
65 °C   30’’ 
68 °C   6’ 
68 °C   10’ 
4  °C    ∞ 
 
 
   20x 
 
 
Initial denaturation  
Denaturation 
Annealing 
Extension 
Final Extension 
End 
98 °C   2’ 
98 °C   30’’ 
68 °C   30’’ 
72 °C   6’ 
72 °C   10’ 
4  °C    ∞ 
 
 
   20x 
 
 
 
 
Table 2 Primers used for site directed mutagenesis PCR 
 Forward Primer 5’     3’ Reverse Primer 5’     3’ 
sEH1H2 444 STOP CCTTGGTGGCGCTTAAGGGCCC
TTC  
AGCGCCACCAAGGACCGTATGT
AC 
sEH1H2 448 STOP GCTTTCAACAGCATCTAAGGGC
CCTTC  
GATGCTGTTGAAAGCGCCACCA
AGG 
sEH1H2 444 SSTREP TCCACAATTCGAGAAGTGAGTTT
GAGGCGGCGG 
TTCTCGAATTGTGGATGACTCC
AACCGGCC 
sEH1H2 448 SSTREP TCCACAATTCGAGAAGTGAGTTT
GAGGCGGCGG 
TTCTCGAATTGTGGATGACTCC
AACCGGCC 
 
 
4.1.7 Transformation of chemically competent bacteria 
50µl of DH5α-T1R competent E. coli (Invitrogen) were transformed with 5µl DNA 
according to the manufacturer´s protocol. Transformed bacteria cells were plated on 
LB plates, containing ampicillin (LB +amp) to select bacteria carrying the ampicillin 
resistance gene in the vector. Plates were incubated overnight (16 h) at 37°C to allow 
bacterial growth. 
 
LB medium  10g Bacto tryptone 
  5g Yeast extract 
  10g NaCl 
  ddH2O to a final volume of 1 liter 
  adjusted to pH 7.0 with NaOH 
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LB +amp medium  LB medium, containing 100µg/ml ampicillin 
 
LB agar medium     LB medium, containing 20g/l difco agar  
 
 
4.1.8 Plasmid preparation 
Single E.coli colonies grown on LB +amp plates were picked to inoculate liquid 
LB+amp medium. These cultures were harvested after 16 h at 37°C under shaking 
conditions. DNA was purified in small scale either with the PureYield™ Plasmid 
Miniprep System (Promega) or the PureYield™ Plasmid Midiprep System (Promega) 
according to the manufacturer´s protocol. If ethanol was retained in the sample after 
purification, ethanol was precipitated as explained in 4.1.9. 
The concentration of DNA was determined with the Nano Drop 1000 (Peqlab).  
 
 
4.1.9 Ethanol precipitation of DNA 
DNA samples were mixed with 1/10 volume sodium acetate (pH=5.2) and three 
volumes of 96% ethanol. The mixture was incubated for 15 minutes at -20°C. DNA 
was pelleted by centrifugation at 14,000 rpm (Eppendorf, 5417R) for 20 minutes at 
4°C. Afterwards the DNA pellet was washed with cooled 70% ethanol and dried for 
several minutes prior to resuspension in nuclease free ddH2O. 
 
 
4.1.10 DNA sequencing 
Sequence analysis was carried out using the ABI Prism Big Dye Terminator 
Cycle Sequencing Kit according to the manual. 300-500ng DNA and 6pmol primer 
were added to 4μl Big Dye Ready Mix and filled up with nuclease free ddH2O to a 
volume of 20µl. The reaction for DNA sequencing was performed with the settings 
shown in table 3. 
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Table 3 Settings for the reaction of DNA sequencing 
Reaction Settings   
Initial denaturation 
Denaturation 
Annealing 
Extension 
End 
96 °C   20’’ 
96 °C   30’’ 
50 °C   15’’ 
60 °C   4’ 
4  °C    ∞ 
 
 
   35x 
 
 
 
 
The amplified, labeled DNA products were purified by centrifugation through 
swelled Sephadex plates and were analyzed by an automatic capillary sequencer 
(Applied Biosystems, GA 3100). The results were evaluated with the software 
Geneious Pro™ 5.3 (Drummond AJ, 2011). 
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4.2 Cell culture 
4.2.1 Drosophila melanogaster Expression System (DES) 
The DES was developed by the SmithKline Beecham Corporation and is 
proprietary to this company. The DES is licensed to Invitrogen Corporation. Materials 
of the kit are the subject of U.S. Patents No. 5,5500,043, 5,681,713 and 5,705,359. 
The Drosophila melanogaster Schneider 2 cell line (S2 cell line) from Invitrogen 
was maintained in Schneider’s complete Drosophila medium (Fisher Scientific) with 
10% fetal calf serum (FCS) and 1% antibiotic antimycotic solution (penicillin, 
streptomycin and amphotericin B) purchased from Gibco. Selection medium included 
25μg/ml Blasticidin (Fisher Scientific). For protein expression, serum-free medium 
(Lonza) with 1% antibiotic antimycotic solution (penicillin, streptomycin and 
amphotericin B) and 10μg/ml Blasticidin (Fisher Scientific) was used.  
 
 
4.2.2 Stable transfection of S2 cells 
In order to stably transfect S2 cells, cultures were grown in 6-well plates to a 
density of 2-4x106 cells/ml. A reaction mix of 36µl 2M CaCl2, 1µg selection vector 
pCoBlast and 19µg recombinant DNA in a volume of 300µl was dropwise added to 
300µl 2xHBS and incubated at room temperature for 40 minutes. The mix was added 
to the S2 cells and cells were incubated at 28°C for 24 h. Subsequently, cells were 
washed twice with Schneider’s complete Drosophila medium. Cells were washed by 
centrifugation at 100g for 10 minutes and resuspended in fresh medium. After 48h at 
28°C cells were selected by changing medium to selection medium containing 
Blasticidin. Every two days, medium was exchanged and the cell density was 
measured until resistant cells started growing. After approximately three weeks of 
selection, stably transfected cell lines were obtained. 
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4.2.3 Subculturing of S2 cells 
S2 cells were grown in complete selection medium at 28°C and split at a cell 
density of 1x107 cells/ml. To adapt cells to serum free medium, S2 cells were 
consecutively split into medium with 50%, 75% and finally 100% serum free medium 
and grown in shaking suspension cultures at 28°C. 
Cells were counted with Nexelcom Bioscience Cellometer Auto T4. 
 
 
4.2.4 Protein expression and purification 
4.2.4.1 Optimization of induction of protein expression 
To optimize protein expression transfected cells were grown to a density of 
2x106 cells/ml and expression was induced with 0mM, 0.75mM, 1.0mM or 1.25mM 
CuSO4. Samples were taken at different time points after induction until the cell 
density reached 1-2x107 cells/ml, typically after seven to nine days. Protein 
expression was measured by a quantitative four-layer ELISA, described in 4.3.2.1. 
 
 
4.2.4.2 Expression of protein 
Stably transfected cells were adapted to serum free medium (4.2.3) and seeded 
at a density of 2 x106cells/ml. Protein expression was induced with 1.0mM CuSO4. 
500ml of cell suspension were incubated seven to nine days under shaking 
conditions until the cell density reached about 1x107cells/ml. Afterwards the cell 
culture supernatant (in the presence or absence of detergent) was cleared by 
centrifugation at 4,000g for 30 minutes at room temperature and filtration through a 
0.22µM filter (Steritop,VWR). The cleared supernatant was concentrated to 1/5 of the 
original volume using Vivaflow 200 system (Sartorius) according to the 
manufacturer’s protocol. 
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4.2.4.3 Purification 
4.2.4.3.1 Cation ion exchange chromatography (IEX) 
Concentrated cell culture supernatant containing tag-less recombinant sE was 
subjected to cation ion exchange chromatography using HITRAP SP FF columns 
(GE Healthcare) and the ÄKTA fast protein liquid chromatography (FPLC) system 
from GE Healthcare. The medium was exchanged to 20mM MES, pH=6.1, 
0.5% DDM (Sigma Aldrich ®) with PD-10 (GE Healthcare) desalting columns prior to 
purification. Then, the protein was applied to the column and washed with 20mM 
MES pH=6.1, 1M NaCl to remove unspecifically bound protein. The protein was 
eluted with a linear NaCl gradient (0- 2M NaCl in a buffer of 10mM MES pH=6.1; 
0.5% DDM) and collected in 1 ml fractions. 
 
 
4.2.4.3.2 Small scale purification by affinity chromatography with streptactin 
Concentrated cell culture supernatant (pH=7.5) (4.2.4.2) was mixed with avidin 
to a final concentration of 15µg/ml and subjected to an equilibrated streptactin spin 
column (Biotag). The recombinant protein bound to the column matrix via its strep 
tag. The column was washed with 400µl buffer W pH=8.0 (100mM Tris/HCl; 150mM 
NaCl; 1mM EDTA) and recombinant protein was eluted with buffer W pH=8.0, 
containing 2mM D-Biotin. All steps were carried out according to the manufacturer’s 
protocol. 
 
 
4.3 Biochemical characterization 
4.3.1 Coflotation assay 
4.3.1.1 Liposome Production and Extrusion 
Phosphatidylcholine (PC), phosphatidylethanolamine (PE) (Avanti Polar Lipids) 
and cholesterol (Sigma) were mixed in a ratio of 1:1:2 from stock solutions in 
chloroform. The mixture was dried to a thin film using a rotary evaporator and then 
dried further in high vacuum for at least 1.5h. The lipid film was hydrated in 10mM 
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triethanolamine (pH=8.0), 140mM NaCl and subjected to five cycles of freeze-
thawing, followed by 21 cycles of extrusion through two polycarbonate membranes 
with a pore size of 200nm using a Lipofast syringe-type extruder (Avestin, Ottawa, 
Canada). 
 
 
4.3.1.2 Enterokinase (EK) cleavage 
Cleavage was carried out for 30 minutes at 4°C at a ratio of protein to enzyme 
of 1µg sE to 0.05 units EK. 
 
 
4.3.1.3 Coflotation 
Purified sEH1 was acidified with MES to a pH of 5.4 in the presence of 
liposomes (at a ratio of 1µg sE to 15nMol Lipid). The mixture was incubated for 
30 minutes at 37°C, adjusted to 20% sucrose and loaded on a 50% sucrose cushion. 
It was overlaid with 15% and 5% sucrose. All sucrose solutions were prepared in 
TAN buffer pH=8.0. After 1.5h centrifugation at 4°C and 50,000 rpm (SW 55 
Beckman Coulter rotor), the top fraction was harvested and the amount of protein 
was determined by a quantitative four-layer ELISA (described in 4.3.2.1). 
 
 
4.3.2 ELISA 
4.3.2.1 Quantitative four-layer ELISA 
96 well microtiter plates (Nunc Maxisorp Microtiter plates) were coated with 
polyclonal guinea pig anti-flavivirus IgG (2,5µg/ml in carbonat coating buffer pH 9.6) 
for 2-4 days at 4°C in a humid chamber. Purified TBEV (strain Neudoerfl) or sE 
protein were used as internal standards. Samples and standard were denatured with 
0.4% sodium dodecyl sulfate (SDS) at 65°C and then diluted in ELISA buffer. 
Aliquots of 50µl of sample were applied to the microtiter plates and incubated for 1.5h 
at 37°C in a humid chamber. After washing the plates four times with washing buffer, 
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rabbit anti-TBEV serum was added, incubated for 1h at 37°C and then washed again. 
A donkey anti-rabbit IgG, peroxidase-linked antibody and O-phenyldiamine as 
substrate were used for detection as described previously (Heinz et al., 1994). The 
reaction was stopped with 2N H2SO4. Absorbance was measured at 490/630nm in a 
multichannel photometer and concentrations were determined with the KCjunior 
software (BioTek). Used antibodies are listed in table 4.  
 
Table 4 Antibodies used in Quantitative four-layer ELISA 
Antibody Type of Ab Company Concentration 
Guinea pig anti-flavivirus IgG polyclonal  2.5 µg/ml 
Rabbit anti-TBEV serum polyclonal  Lot-dependent 
Donkey anti-rabbit IgG, peroxidase-
linked species-specific whole antibody 
polyclonal GE 
Healthcare 
Lot-dependent 
 
 
 
4.3.2.2 Conformational analysis by ELISA 
The conformation of different trimers was investigated with monoclonal 
antibodies (mabs). 96 well microtiter plates (Nunc Maxisorp Microtiter plates) were 
coated with 1µg/ml protein specific mabs (4G2 or B2) in carbonate coating buffer pH 
9.6 for two days at 4°C in a humid chamber. Trimer preparations were serially diluted 
in ELISA buffer from 1 to 0.000333µg/ml, applied to the plates and incubated for 1.5h 
at 37°C in a humid chamber. Further procedures as described in 4.3.2.1. Used 
antibodies are listed in table 5.  
 
Table 5 Antibodies used in Conformational analysis by ELISA 
Antibody Type of Ab Company Concentration 
4G2 monoclonal  1 µg/ml 
B2 monoclonal  1 µg/ml 
Rabbit anti-TBEV serum polyclonal  Lot- dependent 
Donkey anti-rabbit IgG, peroxidase-
linked species-specific whole antibody 
polyclonal GE Healthcare Lot dependent 
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4.3.2.3 ELISA buffers 
0,05M Carbonate buffer pH=9,6    1.59g Na2CO3  
2.93g NaHCO3 
H2Odd to a final volume of 1l 
 
PBS pH=7.4        137mM NaCl 
1.76mM KH2PO4 
10mM Na2HPO4*12 H2O 
2.7mM KCl 
 
ELISA buffer        PBS pH=7.4 
2% Tween-20 
2% Lamb serum 
 
Washing buffer       PBS pH=7.4 
0.05% Tween-20 
 
Peroxidase Substrat      1mg/ml o-Phenylendiamin (OPD) in 
Phosphat-Citrat buffer pH=5.0   90% 0.11M Na2HPO4*2 H2O  
10% 0.5M C6H8O7* H2O 
0.3% H2O2  
 
 
4.3.3 Sedimentation analysis 
The oligomeric state of sE proteins was measured by sedimentation analysis as 
described previously (Allison et al., 1995a). As controls, solubilized low-pH-pretreated 
(E trimer control) and untreated (dimer control) virus preparations were included 
(Allison et al., 1995a). 3µg sE, solubilized virus-derived E trimers and E dimers in 
TAN buffer pH 8.0 containing detergent (e.g. 0.5-1% Triton X-100) were applied to 7 
to 20% continuous sucrose gradients containing 0.1% Triton X-100. Samples were 
centrifuged for 20h in an SW 40 rotor (Beckman) at 38,000rpm and 15°C. Fractions 
were collected by upward displacement (Biocomp Piston Fractionator), and E protein 
was determined by a quantitative four-layer ELISA after denaturation with 0.4% SDS 
(4.3.2.1). 
 
 
4.3.4 Chemical cross-linking with DMS 
E protein-containing fractions from sedimentation analyses were subjected to 
cross-linking with 10mM dimethylsuberimidate (DMS) for 30 minutes at room 
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temperature as described previously (Allison et al., 1995a). The reaction was stopped 
by the addition of ethanolamine to a final concentration of 10mM. The cross-linked 
samples were precipitated as described (4.3.5) and separated by electrophoresis on 
5% SDS polyacrylamide gels using a phosphate-buffered system (4.3.7), blotted onto 
polyvinylidene difluoride membranes (Bio-Rad) using a Bio-Rad Trans-Blot semidry 
transfer cell, and detected and visualized immunoenzymatically (4.3.8) 
 
 
4.3.5 Protein precipitation with deoxycholic acid (DOC) and tricholoracetic 
acid (TCA) 
Protein solutions (with or without prior cross-linking) were incubated with 
0.0015% DOC for 30 minutes at room temperature and then precipitated with 8% 
TCA overnight on ice, followed by centrifugation for 10 minutes at 14,000g and 4°C. 
The pellet was washed three times with ice cold acetone (14,000g, 10 minutes, 4°C) 
and dissolved in 20µl of the respective sample buffer 
 
 
4.3.6 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) according to 
Laemmli 
The electrophoresis was performed at 20 mA/gel using 0.75 mm thick gels with 
a 3% stacking gel and a 12% or 15% separation gel. A pre-stained rainbow molecular 
weight marker (high range RN756E – 225; 76; 52; 38; 31; 24; 17; 12 kDa) from GE 
Healthcare was used.  
For staining, the gels were shaken for 30 minutes in the fixation solution and 
then for 30 minutes in the Coomassie solution. After destaining, the gel was dried 
using a gel dryer (Model 543, BioRad) according to the manufacturer’s instruction.  
3% stacking gel 385µl 40% Acrylamide 
 625µl 1M Tris (pH=6.8) 
 3.92ml ddH2O 
 50µl 10% SDS 
 25µl Ammonium persulfate (APS) 
 5µl N,N,N´,N´-tetramethyl-ethylendiamine (TEMED)  
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15% separation gel 1.88ml 40% Acrylamide 
 1.25ml 1,5M Tris (pH=8.8) 
 1.8ml ddH2O 
 50µl 10% SDS 
 25µl APS 
 5µl TEMED 
 
Laemmli sample buffer 0.125M Tris (pH=6.8) 
 2% SDS 
 10% Glycine 
 0.0025% Bromphenol blue 
 5% ß-Mercaptoethanol 
 
 
5x Running buffer 60g Tris 
 288g Glycine 
 ddH2O to a final volume of 2000 ml 
 0,1% SDS prior to use 
Fixation solution 50% (v/v) Ethanol 
 10% (v/v) Acetic acid 
 
Coomassie solution 0.1% (w/v) Coomassie blue R350 
 20% (v/v) Methanol 
 10% (v/v) Acetic acid 
 
Destaining solution 50% Methanol 
 10% Acetic acid 
 
 
4.3.7 SDS-PAGE according to Maizel  
The electrophoresis was performed at 20 mA/gel using 0.75 mm thick 5% gels. 
A pre-stained rainbow molecular weight marker (complete range RNP800E – 225; 
150; 102; 76; 52; 38; 31; 24; 17; 12 kDa) from GE Healthcare was used.  
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Gels were used for semidry western blotting as described in 4.3.8 
5% gel (5ml) 625µl 40% Acrylamide 
 500µl 1M Sodium-Phosphate 
 3.795ml ddH2O 
 50µl 10% SDS 
 25µl APS 
 5µl TEMED 
Sample buffer (10ml)  2ml 10%SDS 
      1.15ml Glycerine 
      250µl Bromphenolblue (1%) 
      100µl 1M Sodium-Phosphate 
      6.5ml ddH2O 
 
Running buffer   0.1M Sodium-Phosphate 
      0.1% SDS 
 
 
4.3.8 Semidry Western blotting 
0,3µg-1µg purified protein or virus were subjected to SDS-PAGE as described 
above. A polyvinyldifluoride (PVDF, BioRad) membrane was soaked in methanol 
(Merck) for 5 minutes and then- together with the gel- equilibrated in blotting buffer. 
The proteins were transferred for 1.5h at 18V onto the PVDF membrane with a 
Semidry Transfer Cell from BioRad. The membrane was blocked overnight at 4°C 
with 1% bovine serum albumin in PBS pH= 7.4 containing 0.1% Tween-20. The 
respective primary antibody (Table 6), diluted in blocking buffer, was added for 2h at 
room temperature. The membrane was washed and incubated with the 
peroxidase-labeled lgG-specific secondary antibody for 1.5h at room temperature. 
The substrate reaction was carried out with the SIGMAFASTTM DAB tablets. Used 
antibodies are listed in table 6. 
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Table 6 Antibodies used in Semidry Western blotting 
 Primary antibody 
Anti Strep Tag Western blot Monoclonal anti-strep tagII 
Western blot to visualize Crosslinking assay Polyclonal rabbit anti-TBEV serum KP-M2 
 
 
 
Blotting buffer 5.82g Tris 
 2.93g glycine 
 3.75ml 10% SDS 
 200ml Methanol 
 ddH2O to a final volume of 1l 
Blocking buffer 1% BSA 
 0.2% Tween-20 
 in PBS pH=7.4 
 
  
 
 
45 
 
  
5 Results 
5.1 Generation of sE trimers containing helix 1 of the stem region 
(sEH1) 
Purified sEH1 dimers containing double strep tag (sEH1 dstrep), produced in 
stably transfected Drosophila S2 cells, were previously used for trimer productions 
(Geller, 2009) (unpublished data). Unfortunately, the sE trimers did not crystallize 
(unpublished data). Therefore, tag-less sEH1 trimers were generated in this diploma 
thesis. For this purpose, purified sEH1 dimers were cleaved with enterokinase to 
remove the strep tag and acidified in the presence of liposomes to induce 
trimerization (Material and Methods). Subsequently, liposome-associated trimers 
were separated from unbound material by centrifugation in sucrose step gradients 
(Material and Methods). The top fraction, containing the liposome bound trimers, was 
solubilized with detergent and lipids were removed by ultrafiltration (Material and 
Methods). To exclude tag-containing trimers that might still be present in the 
preparations, the trimers were subjected to a small-scale streptactin affinity 
chromatography, using spin columns (Material and Methods). Typically, the recovery 
of tag-less sEH1 trimers was about 40-50% of the input material. A representative 
example of the procedure is shown in figure 13. 
To confirm the trimeric state of the final product, a sedimentation analysis in the 
presence of detergent was carried out. As shown in figure 14, the protein was 
exclusively found in the fractions corresponding to a trimer. 
To determine the homogeneity and the removal of the tag of the sEH1 trimer, 
an SDS-PAGE and a Western blot using a strep tag-specific monoclonal antibody 
were carried out. As controls, sEH1 dimers (before and after partial enterokinase 
cleavage of the strep tag), and TBEV were included. In the case of the sEH1 trimer, 
most of the protein migrated as a single band at the expected size (Figure 15 A) and 
did not react with the monoclonal antibody (Figure 15 B) indicating that the tag-
removal was successful.  
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Figure 13 Recovery diagram of sEH1 trimer conversion. Samples were quantified by a 
four-layer ELISA. 
 
 
 
Figure 14 Sedimentation analysis of sEH1 trimers in the presence of detergent. The 
sedimentation direction is indicated from left to right. The position of the trimer (T) is 
highlighted. 
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5.2 Generation of sE trimers containing the stem region (sEH1H2) 
The first attempts to purify recombinant sEH1H2 proteins containing the whole 
stem region and a double strep tag from stably transfected Drosophila S2 cells was 
unsuccessful (unpublished data). The recovery of the protein after purification using 
streptactin affinity chromatography was below 10% (unpublished data). The 
experiments indicated that the increase in hydrophobicity of sEH1H2 compared to 
sEH1 led to aggregation of the proteins in the cell culture supernatant and impaired 
their binding to streptactin. Furthermore, the elution of the (probably aggregated) and 
via the strep-tag bound sEH1H2 proteins was very inefficient (unpublished results). 
Therefore, new constructs were designed for the production of sEH1H2 proteins 
using the Drosophila expression system (Figure 16). 1) The last 4 amino acids of 
helix 2 were deleted to decrease the hydrophobicity of the protein (sEH1H2 444 dstrep), 
2) the second strep tag was deleted to facilitate elution from the streptactin columns 
(sEH1H2 448 strep and sEH1H2 444 strep), and 3) the strep tag was deleted completely 
  
Figure 15 (A) Coomassie-stained 12% SDS-PAGE and (B) Western blot using an 
anti-strep-tag mab. TBEV and TBE sEH1 dstrep dimer were used as controls. 
EK: Enterokinase 
TBE sEH1Trimer: Final trimer preparation 
M: Marker  
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(sEH1H2 448 and sEH1H2 444). For the sEH1H2 proteins without tag other purification 
strategies such as ion-exchange chromatography had to be established. 
All new expression plasmids were based on the already existing sEH1H2 448 
dstrep construct (Geller, 2009) (Figure 16) (Material and Methods).  
 
Constructs Protein 
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Figure 16 Schematic representations of the C-terminal truncation and modification of 
recombinant E proteins. The schematic shows details of the flavivirus genome organization 
in the corresponding constructs (left panel) and the resulting E proteins (right panel) 
WT: wildtype E protein with the stem–anchor region (496 amino acids) 
sEH1H2 448: contains the whole stem region (448 amino acids) 
sEH1H2 444: sEH1H2 448 without the last four amino acids (444 amino acids) 
Color code: DI red, DII yellow with the fusion peptide in green, DIII blue, stem region purple, 
transmembrane anchor grey, red triangle symbolizes ATG stop codon, black asterisk 
enterokinase cleavage site.  
 
 
5.2.1 Production of expression plasmids  
5.2.1.1 Generation of the expression plasmid sEH1H2 444 with a double strep 
tag (sEH1H2 444 dstrep) 
To generate the plasmid encoding sEH1H2 444 with a double strep tag 
(sEH1H2 444 dstrep), the 3’-terminal part of the gene coding for the E protein was 
synthesized (sEH1H2_del) (Figure 17). This region contains two unique restriction 
sites, PasI and ApaI. The expression vector sEH1H2 448 dstrep and the synthesized 
vector were digested with the restriction enzymes ApaI and PasI (Figure 17) and the 
cleavage reactions were separated on an agarose gel (Figure 18). The appropriate 
gel fragments were isolated and ligated as described in Material and Methods. E. coli 
DH5α bacteria were transformed with the ligation product and selected on agarose 
plates containing ampicillin. Single colonies were picked and inoculated in medium 
for propagation. The DNA was isolated and the coding sequence was verified by 
sequencing (Material and Methods). 
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Figure 17 Schematic representation of the cloning strategy of sEH1H2 444 dstrep. The 
expression vector sEH1H2 448 dstrep and the synthesized plasmid sEH1H2_del, encoding for 
parts of the E protein and a shortened stem region (until amino acid 444 ), were cut with the 
restriction enzymes ApaI and PasI. The cut vector sEH1H2 448 dstrep and the fragment 
sEH1H2_del were ligated. Color code: green the prM/M protein, blue the E protein, purple the 
stem region, grey restriction sites, the pUC origin and the double strep tag. Plasmids were 
drawn with Geneious v5.4 (Drummond AJ, 2011) and Photoshop. 
 
 
 
Figure 18 Analytical agarose gel electrophoresis of the cleaved insert of sEH1H2_del and 
the linearized expression vector sEH1H2 448 dstrep. The insert (205bp) and the vector (5217bp) 
were separated according to their molecular weight by a 1% agarose gel. The red rectangle 
highlights the insert at 205bp. 
 
 
5.2.1.2 Generation of expression plasmids for sEH1H2 with single strep tag or 
without tag 
To generate the expression vectors for sEH1H2 without tag (sEH1H2) or 
sEH1H2 with a single strep tag (sEH1H2 sstrep), ATG stop codons were inserted at 
different positions of the expression plasmids by site directed mutagenesis PCR as 
described in Material and Methods. To obtain sEH1H2 without tag, an ATG stop 
codon was inserted after helix 2. To gain sEH1H2 with a single strep tag, an ATG 
b
p 
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stop codon was inserted after the first strep tag. The PCR products were checked by 
sequencing (Material and Methods), which confirmed successful mutagenesis 
reactions. 
 
 
5.2.2 Expression of recombinant sEH1H2 in Drosophila melanogaster S2 cells 
5.2.2.1 Stable transfection of S2 cells and optimization of protein expression 
For expression of the different recombinant proteins, Drosophila melanogaster 
Schneider S2 cells were cotransfected with the respective expression plasmid and 
the selection vector pCoBlast, with a Blasticidin resistance gene. Transfected cells 
were selected with medium (containing Blasticidin) for two weeks as described in 
Material and Methods. Protein expression was induced in stably transfected cells by 
the addition of copper sulphate (CuSO4) and the amount of protein secreted into the 
cell culture supernatant was determined by quantitative four-layer ELISA (Material 
and Methods). 
To optimize induction and protein expression different CuSO4 concentrations 
were compared and the course of protein expression was monitored for nine days. 
Protein secreted into cell culture supernatant was quantified by four-layer ELISA 
(Material and Methods). As an example, the expression of sEH1H2 444 is shown in 
figure 19. The highest expression levels were observed after induction with 1mM and 
1.25mM CuSO4 at day nine. Cell density reached approximately 2x10
7 cells/ml after 
7-10 days of induction. Since 1.25mM CuSO4 occasionally caused decreased cell 
growth and cell death, 1mM CuSO4 was used for all experiments. At the time point of 
harvest the pH of the cell culture supernatant was in the range of 6.1 to 6.5.  
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Figure 19 Time course of sEH1H2 444 secretion into the cell culture supernatant of stably 
transfected S2 cells as quantified by a four-layer ELISA. Days after induction with different 
CuSO4 concentrations are depicted on the abscissa. 
 
 
5.2.3 Small scale purification of sEH1H2 444 dstrep 
In order to express sEH1H2 444 dstrep, the respective stably transfected S2 cells, 
were induced with 1mM of CuSO4 in serum free medium. Cell culture supernatant 
was harvested at a cell density of 1-2x107 cells/ml at day nine, was clarified and 
concentrated by ultrafiltration (Material and Methods). sEH1H2 444 dstrep was purified in 
small scale by affinity chromatography, making use of the binding of strep tag II to the 
streptactin resin. The purification was carried out as described in Material and 
Methods. Briefly, the concentrated cell culture supernatant was applied to 
equilibrated streptactin spin columns. Bound protein was eluted with 2mM D-Biotin. 
The concentration of the E protein was determined in a quantitative four-layer ELISA. 
As shown in figure 20 and reminiscent of sEH1H2 448 dstrep (unpublished data), about 
80% of the protein did not bind to the streptactin spin column and only 2% of the 
attached material could be eluted with D-Biotin (Figure 20). 
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Figure 20 Recovery diagram of purification of sEH1H2 444 dstrep with a streptactin spin column 
as measured by a quantitative four-layer ELISA. Amount of E protein in the original cell 
culture supernatant (CC SN) was defined as 100%. 
FT: Flow through the affinity column 
Eluat: Bound protein eluted by D-Biotin from the affinity column 
 
 
5.2.4 Prevention of aggregation of sEH1H2 proteins 
To test the hypothesis whether sEH1H2 448 and sEH1H2 444 form aggregates in 
the cell culture supernatant (that are unable to bind to streptactin columns), 
solubilization experiments with different detergent, were carried out. For this purpose, 
cell culture supernatant containing sEH1H2 448 was solubilized with CHAPS, n-Octyl-
ß-D-glycopyranoside (n-OG), n-Dodecyl-ß-D-maltoside (DDM) or Triton X-100 (TX-
100). CHAPS, a zwitterionic detergent, is not suitable for crystallization, but can be 
easily removed prior to crystallization, because of its low micelle molecular weight 
(6.2 kDa). The other three detergents are non-ionic, with n-OG and DDM being 
suitable for crystallization. In contrast TX-100, is not recommended for crystallization 
(Prive, 2007) and its removal is difficult due to its high micelle molecular weight 
(88 kDa). TX-100, however, was included as a control, because of its previous use in 
the solubilization of full-length E trimers (Allison et al., 1995a; Stiasny et al., 2005). 
Cell culture supernatant samples of 800µl were incubated for one hour at room 
temperature with 200µl of the respective detergent and then centrifuged for 30 
minutes at 4°C at 14,000 rpm (Eppendorf, 5417R). The supernatants were collected 
and pellets were resuspended in the previous volume with TAN buffer pH=8.0 with 
0.5 % TX-100. The amount of E protein in both fractions was determined by a 
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quantitative four-layer ELISA (Figure 21). 
Solubility of sEH1H2 448 could be increased with all four detergents compared to 
the control without detergent in which 42% of the material was found in the pellet 
(Figure 21). After incubation with TX-100 or DDM about 98% of the protein was found 
in the supernatant, while in the presence of n-OG 95% of the protein was found in the 
supernatant (Figure 21). With CHAPS 75% of the protein was detected in the 
supernatant (Figure 21). 
 
Figure 21 Recovery diagram of solubilization and low-speed centrifugation of sEH1H2 
containing cell culture SN using different detergents. sEH1H2 448 concentration after 
centrifugation was determined in supernatant and pellet by a quantitative four-layer ELISA.  
 
 
5.2.5 Purification of sEH1H2 448 without tag 
Since tag-less proteins containing the whole stem region would be preferred for 
crystallization trials, it was attempted to purify the protein via ion-exchange 
chromatography similar to the method described by Nayak et al. (Nayak et al., 2009). 
For this purpose, Schneider S2 cells stably transfected with the sEH1H2 448 plasmid 
were adapted to serum free medium and scaled up to 500ml (Material and Methods). 
After induction of expression, cells were propagated for nine days, harvested, 
solubilized with N-Dodecyl ß-D-maltoside (DDM), and clarified. After a buffer 
exchange into 20mM MES (pH=6.1) containing DDM, sEH1H2 448 was subjected to 
cation-exchange chromatography using HITRAP SP FF columns as described in 
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Material and Methods. The amount of E protein in the collected fractions was 
quantified by a four-layer ELISA (Material and Methods). As shown in figure 22 A and 
figure 22 B, the peak containing E protein represented about 40% of the input 
material. In the FPLC UV absorbance profile (Figure 22 C), a broad peak was 
observed with a small shoulder at the position of sEH1H2 448 indicating a low purity of 
the sEH1H2 448 protein which was confirmed by SDS-PAGE (Figure 23). Further 
optimization experiments and additional purification steps or alternative purification 
strategies are required for this protein. 
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Figure 22 (A) sEH1H2 448 in the FPLC fractions quantified by a four-layer ELISA. (B) 
Recovery diagram of sEH1H2 448 purification by cation exchange chromatography. (C) 
Elution profile of cation exchange chromatography. Protein UV absorbance (mAU) in blue. 
SN: applied cell culture supernatant 
IEX 1: IEX flow through 1 
IEX 2 : IEX flow through 2 
Peak: pooled peak fractions 
C 
B 
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Figure 23 Coomassie stained SDS-PAGE. Samples of purification steps of sEH1H2 448. 
Peak fractions five to eight (A5-A8). A7 and A8 are the peak of E protein after IEX 
chromatography. 
SN: applied cell culture supernatant 
FT: Buffer exchange flow through 
IEX 1: IEX flow through 1 
IEX 2 : IEX flow through 2 
 
 
 
5.3 Characterization of sEH1H2 
5.3.1 Oligomeric state of sEH1H2 
To investigate the oligomeric structure of sEH1H2 444/448, a sedimentation 
analysis was carried out as described previously (Stiasny et al., 2004; Stiasny et al., 
2005). Solubilized and concentrated cell culture supernatant of sEH1H2 444 and 
sEH1H2 448 were subjected to sedimentation in 7-20% (wt/wt) continuous sucrose 
gradients that allow a separation of dimers and trimers. Solubilized low pH treated 
(trimer) and untreated (dimer) virus were used as controls. As shown in figure 24 A, 
about 59% of sEH1H2 444 was found in fractions corresponding to dimers and 
approximately 39% in fractions corresponding to trimers. sEH1H2 448 mainly 
sedimented in trimer fractions (~71%) (Figure 24 B). 
To confirm the oligomeric state of the protein, the peak fractions were 
chemically cross-linked with DMS as described in Material and Methods. In the case 
  
 
 
59 
 
  
of sEH1H2 448, a trimeric band was clearly visible, thus confirming the results of the 
sedimentation analysis. The concentration of sEH1H2 444 in the peak fractions was 
too low for cross-linking. 
 
 
Figure 24 Sedimentation analysis of (A) sEH1H2 444 and (B) sEH1H2 448 in the presence of 
detergent. The sedimentation direction is from left to right, the position of dimers (D) and trimers 
(T) are indicated. Inset: Crosslinking of proteins in the peak fractions analyzed on a Western 
blot.  
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5.3.2 Reactivity of sE trimers with monoclonal antibodies 
Since it has been speculated that the stem helix 2 could interact with the fusion 
peptide (FP) (Modis et al., 2004), we probed its accessibility in ELISA with an 
FP-specific mab and trimers with different carboxy-termini. These trimers included 
the truncated sE without the whole stem-anchor region (sE trimer (Stiasny et al., 
2004)), the truncated sE trimer containing helix 1 of the stem (sEH1 trimer), the 
truncated sE trimer containing the whole stem region (sEH1 448 trimer) and the full-
length E trimer isolated from solubilized virions (E trimer). The different trimer 
preparations were captured either with the FP specific mab 4G2 (Stiasny et al., 2006) 
or the DIII specific mab B2 (Kiermayr et al., 2009) (Figure 25). The bound trimers 
were detected with polyclonal rabbit anti-TBEV serum (Material and Methods). As 
shown in figure 26, the FP was fully accessible in the trimers lacking helix 2, whereas 
the reactivity of 4G2 was strongly reduced in the trimers containing helix 2. 
Interestingly, there was no difference in the reactivity of 4G2 with the sEH1H2 trimer 
and the full length E trimer indicating that the shielding of the fusion peptide occurs 
mainly by helix 2 and not the transmembrane domains.  
 
 
Figure 25 Ribbon diagram of the TBEV sE trimer. The balls indicate the position of mutations 
that affected binding of mabs (magenta: B2, green: 4G2). The black star indicates the 
C-terminus where the stem starts. The figure was generated with PyMOL Molecular Graphics 
System, Version 1.3, Schrödinger, LLC.  
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Figure 26 Four-layer ELISA with different trimers and mabs. Absorbance values of 4G2 are 
expressed as percentage of B2 absorbance values. 
sE: sE trimers missing the whole stem-anchor region 
sEH1: sE trimers including helix 1  
sEH1H2 448: sE trimers including the stem region until amino acid 448  
E: full length E trimers from solubilized virions  
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6 Discussion  
The atomic structures of the postfusion sE trimers lack the important stem-
anchor region. Fusion models suggest that the stem zippers along the body of the 
trimer during the low-pH-induced conformational changes of E thereby leading to the 
formation of the stable postfusion trimer and providing part of the energy required for 
fusion (Harrison, 2008; Stiasny and Heinz, 2006). This hypothesis is supported by 
modeling studies with helix 1of the stem (Bressanelli et al., 2004) and a mutagenesis 
study with TBEV RSPs that identified a stem domain II interaction site (Pangerl et al., 
2011). 
In the course of this diploma thesis, recombinant postfusion trimers of TBEV 
containing the stem helix 1 (sEH1) and the whole stem region (sEH1H2 448) were 
generated to shed light on the precise role of the stem in fusion. The proteins were 
produced in the Drosophila expression system. Similar to the recombinant sE 
proteins of dengue virus types2 and 3 lacking the whole stem-anchor region (Modis 
et al., 2003; Modis et al., 2005; Zhang et al., 2004), sEH1 was predominantly 
secreted as a dimer into the cell culture supernatant and could be converted into 
trimers by acidification in presence of liposomes as described previously (Modis et 
al., 2004; Stiasny et al., 2004). In contrast, the cell culture supernatant of stably 
transfected sEH1H2 448 Drosophila S2 cells contained about 80% trimers. Removal of 
four carboxy-terminal amino acids of sEH1H2 decreased strongly the efficiency of 
trimerization (sEH1H2 444) indicating that the complete stem helix 2 acts as a 
“faciliator” for trimerization. However, it is not clear from our data whether 
trimerization already occurred in the cell or in the slightly acidic culture supernatant of 
S2 cells.  
The trimeric structure of sEH1H2 448 probably caused the difficulties observed in 
the attempts to purify the protein. As shown previously, sE trimers lacking the whole 
stem-anchor region were already more hydrophobic than monomers and dimers 
(Stiasny et al., 2004) and the presence of the stem helix 2 further increased the 
hydrophobicity of the protein. This presumably led to the strong aggregation of 
sEH1H2 in the cell culture supernatant and purification procedures will require the 
use of detergents. 
An involvement of pre-transmembrane elements (membrane proximal external 
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regions; MPERs) in fusion was shown for other viral fusion proteins (reviewed in 
(Lorizate et al., 2008)). It has been suggested that the MPERs either transmit protein 
conformational energy into membranes and/or perturb lipid bilayers integrity thus 
facilitating fusion (Lorizate et al., 2008). The stem helix 2 of dengue virus was also 
shown to be able to bind to lipid membranes in an in vitro experiment using a 
recombinant form of helix 2 (Lin et al., 2011). It is thus possible that helix 2 acts in a 
similar fashion as the MPERs of other fusion proteins. In this context, it is important 
to note that stem helix 2 peptides of dengue virus were shown to bind to virions at 
neutral pH, presumably by interacting with the viral membrane, and block low-pH-
induced fusion (Schmidt et al., 2010a; Schmidt et al., 2010b). It has been suggested 
that these peptides interact with an E intermediate generated during the 
conformational changes of E necessary for fusion (Schmidt et al., 2010a; Schmidt et 
al., 2010b). 
Although, purified sEH1H2 448 proteins were not obtained during this thesis, 
preliminary studies using sEH1H2 containing cell culture supernatant and monoclonal 
antibodies allowed a comparison with different trimeric forms of E. These included 
truncated sE trimers lacking the whole stem-anchor region (Stiasny et al., 2004), 
sEH1 containing the first stem helix (this thesis) and full-length E trimers isolated 
from low-pH-treated and solubilized virions (Stiasny et al., 2005). The results 
obtained indicate that helix 2 interacts with the FP at the tip of domain II in the 
postfusion trimer, because an FP specific mab exhibited a similar reduced reactivity 
with full-length and sEH1H2 trimers compared to trimers without helix 2. The stem 
might therefore follow the groove formed by neighboring DIIs with helix 2 extending to 
the FPs, as speculated after elucidation of the atomic structure of sE trimers lacking 
the whole stem-anchor region (Bressanelli et al., 2004; Modis et al., 2004). The FPs 
interact with each other in these truncated sE trimers and it is possible that in the 
full-length trimer the stem keeps the FPs apart, similar to the structurally closely 
related postfusion E1 trimer of alphaviruses (Bressanelli et al., 2004; Gibbons et al., 
2004b). It has been proposed that the more “open conformation” of truncated E1 is 
due to the fact that the stem of this fragment extends further towards the FPs than in 
the case of the flavivirus sE (Bressanelli et al., 2004).  
To determine whether the stem might push the FPs apart and to define the 
precise interactions of the stem with the FPs and other parts of domain II, high 
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resolution X-ray structures of sE trimers containing the stem are necessary. We were 
able to produce recombinant sEH1 trimers in sufficient amounts and quality for 
crystallization trials, but for the isolation and purification of sEH1H2 trimers further 
optimization experiments are required. 
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